Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express α-Gal epitopes: A novel approach to immunotherapy in pancreatic cancer
Dive into the research topics of 'Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express α-Gal epitopes: A novel approach to immunotherapy in pancreatic cancer'. Together they form a unique fingerprint.